ACADIA Pharmaceuticals Investor Relations Material
Latest events
Status Update
ACADIA Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ACADIA Pharmaceuticals Inc
Access all reports
ACADIA Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development and commercialization of therapies addressing central nervous system disorders. The company offers treatments for conditions such as Parkinson’s disease psychosis and other neurological diseases. ACADIA operates within the healthcare sector, concentrating on innovative solutions for underserved medical needs. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Key slides for ACADIA Pharmaceuticals Inc
Status Update
ACADIA Pharmaceuticals Inc
Status Update
ACADIA Pharmaceuticals Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
ACAD
Country
🇺🇸 United States